All Relations between Dementia and dlb

Publication Sentence Publish Date Extraction Date Species
Ian McKeith, John O'Brien, Zuzana Walker, Klaus Tatsch, Jan Booij, Jacques Darcourt, Alessandro Padovani, Raffaele Giubbini, Ubaldo Bonuccelli, Duccio Volterrani, Clive Holmes, Paul Kemp, Naji Tabet, Ines Meyer, Cornelia Reininge. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. The Lancet. Neurology. vol 6. issue 4. 2007-05-11. PMID:17362834. dementia with lewy bodies (dlb) needs to be distinguished from other types of dementia because of important differences in patient management and outcome. 2007-05-11 2023-08-12 Not clear
Ian McKeith, John O'Brien, Zuzana Walker, Klaus Tatsch, Jan Booij, Jacques Darcourt, Alessandro Padovani, Raffaele Giubbini, Ubaldo Bonuccelli, Duccio Volterrani, Clive Holmes, Paul Kemp, Naji Tabet, Ines Meyer, Cornelia Reininge. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. The Lancet. Neurology. vol 6. issue 4. 2007-05-11. PMID:17362834. severe nigrostriatal dopaminergic degeneration occurs in dlb, but not in alzheimer's disease or most other dementia subtypes, offering a potential system for a biological diagnostic marker. 2007-05-11 2023-08-12 Not clear
Haruo Hanyu, Soichiro Shimizu, Kentaro Hirao, Hidekazu Kanetaka, Toshihiko Iwamoto, Taishiro Chikamori, Yasuhiro Usui, Akira Yamashina, Kiyoshi Koizumi, Kimihiko Ab. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. European journal of nuclear medicine and molecular imaging. vol 33. issue 3. 2007-05-09. PMID:16328506. both decreased occipital perfusion on brain single-photon emission computed tomography (spect) and reduction in cardiac (123)i-metaiodobenzylguanidine (mibg) uptake are characteristic features of dementia with lewy bodies (dlb), and potentially support the clinical diagnosis of dlb. 2007-05-09 2023-08-12 Not clear
Haruo Hanyu, Kentaro Hirao, Soichiro Shimizu, Hidekazu Kanetaka, Hirofumi Sakurai, Toshihiko Iwamot. Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease. Neuroscience letters. vol 414. issue 2. 2007-05-08. PMID:17197083. pupillary response test using dilute phenylephrine, a sympathetic agonist, and dilute pilocarpine, a cholinergic agonist, were performed in 24 patients with dementia with lewy bodies (dlb), 40 patients with alzheimer's disease (ad), and 23 normal elderly subjects. 2007-05-08 2023-08-12 human
Henrietta M Nielsen, Elisabet Londos, Lennart Minthon, Sabina M Janciauskien. Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiology of disease. vol 26. issue 1. 2007-05-08. PMID:17270454. we aimed to determine plasma and cerebrospinal fluid (csf) levels of angiotensin-converting enzyme (ace) and the soluble forms of intercellular adhesion molecule-1 (sicam-1), vascular cell adhesion molecule-1 (svcam-1) and platelet endothelial cell adhesion molecule-1 (specam-1) as surrogate markers for endothelial cell activation in clinically diagnosed patients with alzheimer's disease (ad, n=260), dementia with lewy bodies (dlb, n=39) and non-demented controls (n=34). 2007-05-08 2023-08-12 Not clear
Elise Rowan, Ian G McKeith, Brian K Saxby, John T O'Brien, David Burn, Urs Mosimann, Jane Newby, Sarah Daniel, Jonathan Sanders, Keith Wesne. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dementia and geriatric cognitive disorders. vol 23. issue 3. 2007-04-26. PMID:17192712. we examined attention-enhancing effects of the cholinesterase inhibitor donepezil in dementia with lewy bodies (dlb) and parkinson's disease with dementia (pdd) by means of open label study. 2007-04-26 2023-08-12 Not clear
Uwe Walter, Dirk Dressler, Alexander Wolters, Matthias Wittstock, Brigitte Greim, Reiner Beneck. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. Journal of neurology. vol 253. issue 4. 2007-04-25. PMID:16267638. to study the use of transcranial sonography (tcs) in discriminating between patients with dementia with lewy bodies (dlb) and parkinson's disease with dementia (pdd). 2007-04-25 2023-08-12 Not clear
Margaret A Piggott, Clive G Ballard, Heather O Dickinson, Ian G McKeith, Robert H Perry, Elaine K Perr. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. The international journal of neuropsychopharmacology. vol 10. issue 2. 2007-04-16. PMID:16448581. dementia with lewy bodies (dlb) is characterized by progressive dementia with two of three core symptoms; parkinsonism, visual hallucinations or disturbances of consciousness/fluctuating attention. 2007-04-16 2023-08-12 Not clear
Jennifer L Whitwell, Stephen D Weigand, Maria M Shiung, Bradley F Boeve, Tanis J Ferman, Glenn E Smith, David S Knopman, Ronald C Petersen, Eduardo E Benarroch, Keith A Josephs, Clifford R Jac. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain : a journal of neurology. vol 130. issue Pt 3. 2007-04-16. PMID:17267521. dementia with lewy bodies (dlb) is the second most common cause of degenerative dementia after alzheimer's disease. 2007-04-16 2023-08-12 Not clear
C Ballard, R Lane, P Barone, R Ferrara, S Teki. Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias. International journal of clinical practice. vol 60. issue 6. 2007-04-05. PMID:16805745. additional cardiac safety considerations apply in patients with dementia with lewy bodies (dlb) and parkinson's disease (pdd), in whom cardiovascular autonomic nervous system dysfunction is common. 2007-04-05 2023-08-12 Not clear
C F Lippa, J E Duda, M Grossman, H I Hurtig, D Aarsland, B F Boeve, D J Brooks, D W Dickson, B Dubois, M Emre, S Fahn, J M Farmer, D Galasko, J E Galvin, C G Goetz, J H Growdon, K A Gwinn-Hardy, J Hardy, P Heutink, T Iwatsubo, K Kosaka, V M-Y Lee, J B Leverenz, E Masliah, I G McKeith, R L Nussbaum, C W Olanow, B M Ravina, A B Singleton, C M Tanner, J Q Trojanowski, Z K Wszole. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. vol 68. issue 11. 2007-04-05. PMID:17353469. for more than a decade, researchers have refined criteria for the diagnosis of dementia with lewy bodies (dlb) and at the same time have recognized that cognitive impairment and dementia occur commonly in patients with parkinson disease (pd). 2007-04-05 2023-08-12 Not clear
C F Lippa, J E Duda, M Grossman, H I Hurtig, D Aarsland, B F Boeve, D J Brooks, D W Dickson, B Dubois, M Emre, S Fahn, J M Farmer, D Galasko, J E Galvin, C G Goetz, J H Growdon, K A Gwinn-Hardy, J Hardy, P Heutink, T Iwatsubo, K Kosaka, V M-Y Lee, J B Leverenz, E Masliah, I G McKeith, R L Nussbaum, C W Olanow, B M Ravina, A B Singleton, C M Tanner, J Q Trojanowski, Z K Wszole. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. vol 68. issue 11. 2007-04-05. PMID:17353469. this article addresses the relationship between dlb, pd, and pd with dementia (pdd). 2007-04-05 2023-08-12 Not clear
David Weisman, Ian McKeit. Dementia with Lewy bodies. Seminars in neurology. vol 27. issue 1. 2007-04-03. PMID:17226740. synucleinopathies, with and without dementia, encompass a wide range of diseases including parkinson's disease, multiple system atrophy, rapid eye movement (rem) sleep behavior disorder, and dementia with lewy bodies (dlb). 2007-04-03 2023-08-12 Not clear
David Weisman, Ian McKeit. Dementia with Lewy bodies. Seminars in neurology. vol 27. issue 1. 2007-04-03. PMID:17226740. dlb is a neurodegenerative disorder resulting in slowly progressive and unrelenting dementia until death. 2007-04-03 2023-08-12 Not clear
Peter Davison, James Loughma. Effects of retinal image degradation on pre-attentive visual search (PAVS) efficiency for flicker, movement and orientation stimuli. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists). vol 26. issue 5. 2007-03-29. PMID:16918769. previous research has shown that several clinical conditions cause increased pre-attentive visual search (pavs) times, implying reduced parallel search capabilities in glaucoma and dlb dementia. 2007-03-29 2023-08-12 Not clear
Pravat K Mandal, Jay W Pettegrew, Eliezer Masliah, Ronald L Hamilton, Ratna Manda. Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease. Neurochemical research. vol 31. issue 9. 2007-03-29. PMID:16947080. overlap of clinical and neuropathological features of both ad and pd are observed in dementia with lewy body (dlb) disease, the second most common form of dementia after ad. 2007-03-29 2023-08-12 Not clear
Osamu Yokota, Kuniaki Tsuchiya, Toshiki Uchihara, Hiroshi Ujike, Seishi Terada, Mafuyu Takahashi, Yuji Kimura, Hideki Ishizu, Haruhiko Akiyama, Shigetoshi Kurod. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 27. issue 1. 2007-03-29. PMID:17319280. we present here the clinicopathological characteristics of two autopsy cases with both alzheimer's disease and dementia with lewy bodies (dlb), possibly diagnosed as having lewy body variant of alzheimer's disease (lbv/ad). 2007-03-29 2023-08-12 Not clear
Timothy A Crowell, Cheryl A Luis, David E Cox, Michael Mulla. Neuropsychological comparison of Alzheimer's disease and dementia with lewy bodies. Dementia and geriatric cognitive disorders. vol 23. issue 2. 2007-03-23. PMID:17148939. the present study examined the patterns of memory and cognitive performance associated with alzheimer's disease (ad) and dementia with lewy bodies (dlb). 2007-03-23 2023-08-12 Not clear
Haruo Hanyu, Soichiro Shimizu, Yuriko Tanaka, Kentaro Hirao, Toshihiko Iwamoto, Kimihiko Ab. MR features of the substantia innominata and therapeutic implications in dementias. Neurobiology of aging. vol 28. issue 4. 2007-03-22. PMID:16569466. we measured the thickness of the substantia innominata using magnetic resonance imaging in 122 patients with alzheimer's disease (ad), 31 patients with dementia with lewy bodies (dlb) and 34 patients with vascular dementia (vad), and examined the correlates of cognitive response to donepezil. 2007-03-22 2023-08-12 Not clear
Haruo Hanyu, Soichiro Shimizu, Yuriko Tanaka, Kentaro Hirao, Toshihiko Iwamoto, Kimihiko Ab. MR features of the substantia innominata and therapeutic implications in dementias. Neurobiology of aging. vol 28. issue 4. 2007-03-22. PMID:16569466. although all dementia groups showed significant atrophy of the substantia innominata compared to 28 age-matched controls, atrophy was greater in the dlb group, but less in the vad group than the ad group. 2007-03-22 2023-08-12 Not clear